NASHVILLE (WSMV) - The FDA is now reviewing an application submitted by Pfizer in regards to receiving a third dose of the vaccine to help continue to combat the COVID-19 pandemic.

Right now, the booster shot is being offered to those that are immunocompromised which was authorized in August.

Pfizer is now looking for emergency authorization for any person that is 16-years-old or older.

President Biden spoke last week saying that the booster would be available right away to those eligible.

The FDA says they would like to see U.S. data on the booster shot to see if the additional shot will truly help in waning immunity just six months after receiving the second dose.

If the FDA does in fact approve the additional booster, it would then fall on the CDC to determine who qualifies for one.

The President of the World Health Organization says we should concentrate on ensuring more countries have vaccines available before offering additional boosters here. is now with you on the go! Get the latest news updates and video, 4WARN weather forecast, weather radar, special investigative reports, sports headlines and much more from News4 Nashville.

>> Click/tap here to download our free mobile app. <<

Copyright 2020 WSMV (Meredith Corporation). All rights reserved.

Content Producer

Blake was born and raised in Central Ohio where he began working in TV broadcast in 2011 before moving into morning radio. Blake joined the WSMV team in October 2019. Any news stories and ideas can be sent directly to

Recommended for you

(0) comments

Welcome to the discussion.

Keep it Clean. Please avoid obscene, vulgar, lewd, racist or sexually-oriented language.
Don't Threaten. Threats of harming another person will not be tolerated.
Be Truthful. Don't knowingly lie about anyone or anything.
Be Nice. No racism, sexism or any sort of -ism that is degrading to another person.
Be Proactive. Use the 'Report' link on each comment to let us know of abusive posts.
Share with Us. We'd love to hear eyewitness accounts, the history behind an article.